Pulmonary Manifestations of Sjögren's Syndrome

Current Allergy and Asthma Reports

Volumn 13, Issue 4, 2013, Pages 354-360

  Stojan, George ^a   Baer, Alan N ^a   Danoff, Sonye K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bamboo node; Bronchus associated lymphoid tissue; Chronic obstructive pulmonary disease; Cough; Cystic lung disease; Epistaxis; Follicular bronchiolitis; Follicular bronchitis; Hoarseness; Lymphocytic interstitial pneumonia; Nasal septal perforation; Non specific interstitial pneumonia; Pulmonary amyloidosis; Pulmonary hypertension; Sjogren's syndrome; Xerotrachea

Indexed keywords

AMYLOIDOSIS; ARTICLE; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYSTIC LUNG DISEASE; DISEASE ASSOCIATION; FOLLICULAR BRONCHIOLITIS; HOARSENESS; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG LYMPHOMA; LYMPHOCYTIC INTERSTITIAL PNEUMONIA; LYMPHOMA; MORTALITY; NODULAR PULMONARY AMYLOIDOSIS; ORGANIZING PNEUMONIA; PLEURA EFFUSION; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SJOEGREN SYNDROME; UPPER RESPIRATORY TRACT; USUAL ITERSTITIAL PNEUMONIA;

HUMANS; LUNG DISEASES; PLEURAL DISEASES; SJOGREN'S SYNDROME;

EID: 84881131956     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0357-9     Document Type: Article

References (70)

1. Fox RI. Sjögren's syndrome. Lancet. 2005;366(9482):321-31.
2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008 Jan;58(1):15-25.
3. •• Palm O, Garen T, Berge Enger T, Jensen JL, Lund M-B, Aaløkken TM, et al. Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data. Rheumatol Oxf Engl. 2013;52(1):173-9. This retrospective study evaluated 216 patients from the Norwegian systemic CTD and vasculitis registry (NOSVAR) with primary SS for manifestations of pulmonary involvement. 27 % of patients were affected based on CT and PFT findings. The presence of pulmonary involvement negatively impacted both quality of life and mortality pointing to the significance of lung involvement in SS.
4. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008 Jul;87(4):210-9.
5. • Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, et al. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317-24. This retrospective cohort study analyzed features associated with lung involvement among 123 patients with primary SS. Demographic features associated with the risk of lung involvement included smoking, male gender and age. Other clinical features associated with risk of lung involvement were positive RF as well as the presence of anti-Ro and anti-La antibodies. This study suggests that predictors of lung disease risk in primary SS could be developed.
6. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282-9.
7. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med. 1998;19(4):687-99. viii.
8. Doig JA, Whaley K, Dick WC, Nuki G, Williamson J, Buchanan WW. Otolaryngological aspects of Sjögren's syndrome. Br Med J. 1971;4(5785):460-3.
9. Murano E, Hosako-Naito Y, Tayama N, Oka T, Miyaji M, Kumada M, et al. Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice Off J Voice Found. 2001 Sep;15(3):441-50.
10. Prytz S. Vocal nodules in Sjögren's syndrome. J Laryngol Otol. 1980;94(2):197-203.
11. Parke AL. Pulmonary manifestations of primary Sjögren's Syndrome. Rheum Dis Clin N Am. 2008;34(4):907-20.
12. Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61-4.
13. Mathieu A, Cauli A, Pala R, Satta L, Nurchis P, Loi GL, et al. Tracheo-bronchial mucociliary clearance in patients with primary and secondary Sjögren's syndrome. Scand J Rheumatol. 1995;24(5):300-4.
14. Butnor KJ, Khoor A. Collagen vascular diseases and disorders of connective tissue. In: Tomashefski Jr JF, editor. Dail Hammar's Pulm. Pathol. [Internet]. Springer New York; 2008 [cited 2013 Apr 4]. p. 722-59. Available from: http://link.springer.com/chapter/10.1007/978-0-387-68792-6-20
15. Andoh Y, Shimura S, Sawai T, Sasaki H, Takishima T, Shirato K. Morphometric analysis of airways in Sjögren's syndrome. Am Rev Respir Dis. 1993;148(5):1358-62.
16. Tian X, Yi ES, Ryu JH. Lymphocytic interstitial pneumonia and other benign lymphoid disorders. Semin Respir Crit Care Med. 2012;33(5):450-61.
17. Papiris SA, Saetta M, Turato G, La Corte R, Trevisani L, Mapp CE, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am J Respir Crit Care Med. 1997;156(2 Pt 1):637-41.
18. Teruuchi S, Bando M, Hironaka M, Ohno S, Sugiyama Y. [Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis]. Nihon Kokyūki Gakkai Zasshi J. Jpn Respir Soc. 2000;38(12):918-22.
19. Jagirdar J, Chikkamuniyappa S, Sirohi D, McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation. Ann Diagn Pathol. 2013;17(1):113-6.
20. McGrath-Morrow S, Laube B, Tzou S-C, Cho C, Cleary J, Kimura H, et al. IL-12 overexpression in mice as a model for Sjögren lung disease. Am J Physiol - Lung Cell Mol Physiol. 2006;291(4):L837-46.
21. • Mandl T, Diaz S, Ekberg O, Hesselstrand R, Piitulainen E, Wollmer P, et al. Frequent development of chronic obstructive pulmonary disease in primary SS - results of a longitudinal follow-up. Rheumatology. 2012;51(5):941-6. This prospective study followed lung function and radiographic findings in 41 patients with primary SS for over a decade. Over one-third of the patients developed findings consistent with chronic obstructive pulmonary disease over the period of follow-up. This study suggests that both obstructive and restrictive lung disease are common in patients with primary SS.
22. Linstow M, Kriegbaum NJ, Backer V, Ulrik C, Oxholm P. A follow-up study of pulmonary function in patients with primary Sjögren's syndrome. Rheumatol Int. 1990;10(2):47-9.
23. Pertovaara M, Korpela M, Saarelainen S, Laitinen J, Järvenpä ä R, Laippala P, et al. Long-term follow-up study of pulmonary findings in patients with primary Sjögren's syndrome. Scand J Rheumatol. 2004;33(5):343-8.
24. Fox RI. Extraglandular manifestations of Sjögren's Syndrome (SS): dermatologic, arthritic, endocrine, pulmonary, cardiovascular, gastroenterology, renal, urology, and gynecologic manifestations. In: Fox RI, Fox CM, editors. Sjögren's Syndr. [Internet]. Springer New York; 2012 [cited 2013 Apr 4]. p. 285-316. Available from: http://link.springer.com/chapter/10.1007/978-1-60327- 957-4-17
25. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006;130(5):1489-95.
26. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-8.
27. Boitiaux J-F, Debray M-P, Nicaise-Roland P, Adle-Biassette H, Danel C, Clérici C, et al. Idiopathic interstitial lung disease with anti-SSA antibody. Rheumatol Oxf Engl. 2011;50(12):2245-50.
28. Elicker B, Pereira CAC, Webb R, Leslie KO. High-resolution computed tomography patterns of diffuse interstitial lung disease with clinical and pathological correlation. J Bras Pneumol Publicaçao Of Soc Bras Pneumol E Tisilogia. 2008;34(9):715-44.
29. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136-47.
30. Liebow AA, Carrington CB. Lymphocytic interstitial pneumonia. Am J Pathol. 1966;48(36a).
31. Morris JC, Rosen MJ, Marchevsky A, Teirstein AS. LYmphocytic interstitial pneumonia in patients at risk for the acquired immune deficiency syndrome. Chest J. 1987;91(1):63-7.
32. Strimlan CV, Rosenow 3rd EC, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med. 1978;88(5):616-21.
33. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002;122(6):2150-64.
34. Misumi S, Lynch DA. Idiopathic pulmonary fibrosis/usual interstitial pneumonia: imaging diagnosis, spectrum of abnormalities, and temporal progression. Proc Am Thorac Soc. 2006 Jun;3(4):307-14.
35. Lynch DA. Fibrotic idiopathic interstitial pneumonia: high-resolution computed tomography considerations. Semin Respir Crit Care Med. 2003 Aug;24(4):365-76.
36. Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med. 1993;14(4):611-22.
37. Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore). 1995;74(4):201-11.
38. King Jr TE, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest. 1992;102(1 Suppl):8S-13S.
39. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63 Suppl 5:v1-v58.
40. Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K. Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest. 1988;94(2):438-40.
41. Schlegel J, Kienast K, Störkel S, Ferlinz R. [Primary pulmonary nodular amyloidosis and multiple emphysematous bullae in Sjögren syndrome]. Pneumol Stuttg Ger. 1992;46(12):634-7.
42. Bonner Jr H, Ennis RS, Geelhoed GW, Tarpley Jr TM. Lymphoid infiltration and amyloidosis of lung in Sjögren's syndrome. Arch Pathol. 1973;95(1):42-4.
43. Hubscher O, Re R, Iotti R. Cystic lung disease in Sjögren's syndrome. J Rheumatol. 2002;29(10):2235-6.
44. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64(3):347-54.
45. Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg. 2005;80(4):1248-53.
46. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum. 1999;42(8):1765-72.
47. Miller DL, Allen MS. Rare pulmonary neoplasms. Mayo Clin Proc Mayo Clin. 1993;68(5):492-8.
48. Imai H, Sunaga N, Kaira K, Kawashima O, Yanagitani N, Sato K, et al. Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma. Intern Med Tokyo Jpn. 2009;48(5):301-6.
49. Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25(8):997-1008.
50. Koss MN, Hochholzer L, Nichols PW, Wehunt WD, Lazarus AA. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol. 1983;14(12):1024-38.
51. Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer. 1963;16:928-55.
52. Thieblemont C, de la Fouchardière A, Coiffier B. Nongastric mucosa-associated lymphoid tissue lymphomas. Clin Lymphoma. 2003 Mar;3(4):212-24.
53. Röcken C, Sletten K. Amyloid in surgical pathology. Virchows Arch Int J Pathol. 2003;443(1):3-16.
54. Chen KT. Amyloidosis presenting in the respiratory tract. Pathol Annu. 1989;24(Pt 1):253-73.
55. Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90(6):827-31.
56. Gertz MA, Greipp PR. Clinical aspects of pulmonary amyloidosis. Chest. 1986;90(6):790-1.
57. Himmelfarb E, Wells S, Rabinowitz JG. The radiologic spectrum of cardiopulmonary amyloidosis. Chest. 1977;72(3):327-32.
58. Rubinow A, Celli BR, Cohen AS, Rigden BG, Brody JS. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis. 1978;118(3):603-11.
59. Perlat A, Decaux O, Gervais R, Rioux N, Grosbois B. Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2009;16(3):181-2.
60. Delèvaux I, André M, Amoura Z, Kémény JL, Piette JC, Aumaître O. Concomitant diagnosis of primary Sjögren's syndrome and systemic AL amyloidosis. Ann Rheum Dis. 2001;60(7):694-5.
61. Ogihara T, Nakatani A, Ito H, Irokawa M, Ban S, Takahashi A, et al. Sjögren's syndrome with pleural effusion. Intern Med Tokyo Jpn. 1995;34(8):811-4.
62. Alvarez-Sala R, Sánchez-Toril F, García-Martínez J, Zaera A, Masa JF. Primary Sjögren syndrome and pleural effusion. Chest. 1989;96(6):1440-1.
63. Kashiwabara K, Kishi K, Narushima K, Nakamura H, Yagyu H, Kiguchi T, et al. Primary Sjögren's syndrome accompanied by pleural effusion. Nihon Kyōbu Shikkan Gakkai Zasshi. 1995;33(11):1325-9.
64. Suzuki H, Hickling P, Lyons CB. A case of primary Sjögren's syndrome, complicated by cryoglobulinaemic glomerulonephritis, pericardial and pleural effusions. Br J Rheumatol. 1996;35(1):72-5.
65. Kawamata K, Haraoka H, Hirohata S, Hashimoto T, Jenkins RN, Lipsky PE. Pleurisy in primary Sjögren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion. Clin Exp Rheumatol. 1997;15(2):193-6.
66. Tanaka A, Tohda Y, Fukuoka M, Nakajima S. A case of Sjögren's syndrome with pleural effusion. Nihon Kokyūki Gakkai Zasshi J Jpn Respir Soc. 2000;38(8):628-31.
67. Horita Y, Miyazaki M, Kadota J, Watanabe T, Yamashita M, Nishiura K, et al. Type II diabetes mellitus and primary Sjögren's syndrome complicated by pleural effusion. Intern Med Tokyo Jpn. 2000;39(11):979-84.
68. Teshigawara K, Kakizaki S, Horiya M, Kikuchi Y, Hashida T, Tomizawa Y, et al. Primary Sjogren's syndrome complicated by bilateral pleural effusion. Respirol Carlton Vic. 2008;13(1):155-8.
69. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J Off J Eur Soc Clin Respir Physiol. 2009;34(6):1219-63.
70. Launay D, Hachulla E, Hatron P-Y, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86(5):299-315.